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Migraine often runs in families and is associated with both genetic and environmental factors. Clinical and genetic 
heterogeneity as well as the influence of environmental factors have hampered the identification of the gene 
responsible for migraine disorder. Family /twin studies suggest the presence of hereditary susceptibility. Several 
different types of mutations or association studies with genetic polymorphism in neurotransmitters, inflammatory 
cytokines, homocysteine metabolism, mitochondria, or other risk genes in cerebrovascular disorders have been 
reported. Recently, progress of molecular genetics in familial hemiplegic migraine has provided important insights, 
a channelopathy, and now extending to a growing list of membrane excitability disorders. Further identification of 
candidate genes for migraine and exploring the correlation between phenotype and genotype are expected in the 
future for the understanding of migraine pathophysiology.
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INTRODUCTION
Migraine is a common neurological disorder disabling 
about 10~20% of general population. According to a 
population based epidemiological study of migraine in 
Korea, 20.2% of males and 24.3% of females were 
reported to have migraine or probable migraine.
1 It is 
well known that migraine runs in families and is related 
to both genetic and environmental factors. There have 
been several attempts to disclose the genetic factors in 
the pathophysiology of migraine. However, no clear 
diagnostic marker or objective method to assess the 
status of the migraineurs has been established. In the 
studies about migraine, variable clinical manifestations 
and penetrance have posed major difficulties.
2 
To overcome this problem, many studies have used 
the international headache society (IHS) classification in 
selecting patients. The IHS classification distinguishes 
different types of migraine, migraine with aura (MA), 
without aura (MO), etc. Some patients have attacks of 
only one type while one third of patients experience 
both types of attacks during their life. Therefore, 
classification of individuals simply as affected or 
unaffected is difficult. Due to clinical heterogeneity of 
migraine, controversies still remain among the several 
studies using different methodologies, for example, 
including or excluding criteria, or grouping migraineurs 
into MA vs. MO without consideration of probable 
migraine or accompanying secondary headache.
While migraine seems to be a polygenic multi- 
factorial disorder in most cases, there is an exception. Lee JY, et al. Current Issues in Migraine Genetics 
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Epidemiological study
Familial risk pattern
Twin study
Segregation analysis
MA>MO
monozygote>dizygote
mode of inheritance:non-mendemian multifactorial 
Molecular study
Genome wide screen on migraine families
Association analysis with polymorphisms of alleged genes
Linkage analysis on candidate region
SNP investigation 
Genetics of FHM
Linkage analysis between FHM and SHM/or other migraines
Association with hereditary diseases with known genetic abnormalities
4q21,4q24,6p12.2-p21.1,11q24,14q21.2-q22.3
D2,D4 receptors, dopamine β  hydroxylase, 
angiotensin converting enzyme, serotonin transporter,  
serotonin receptor, endothelin type A receptor,  
insulin receptor, tumor necrosis factor, MTHFR gene
1q31,X124-28, X22
exon 8 of CACNA1A gene and epilepsy
mutations on 9p13, 1q23
new locus on 19p13 distinct from CACNA1A
CADASIL, MELAS, CVS
CADASIL; cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, MELAS; mitochondrial 
encephalopathy with lactic acidosis and stroke-like episode, CVS; cyclic vomiting syndrome, MA; migraine with aura, MO; migraine 
without aura, MTHFR; methylene-tetrahydrofolate reductase, SNP; single nucleotide polymorphism, FHM; familial hemiplegic migraine, 
SHM; sporadic hemiplegic migraine
Table 1. Spectrums of migraine genetics and reported data during recent decades
Familial hemiplegic migraine (FHM) is a rare type of 
migraine with aura which is the only form with 
established Mendelian inheritance. The progress in 
molecular findings in FHM has provided important 
insights, the concept of channelopathy, and the basic 
pathogenic mechanisms of migraine disorders. Thus it 
provoked further studies searching for possible genetic 
factors in migraine. Here the recent studies regarding the 
genetics in migraine will be reviewed (Table 1).
EPIDEMIOLOGICAL STUDY
The first step to genetics in migraine is to show the 
genetic influences in this disorder by means of 
epidemiological survey.
Familial risk patterns
A population-based epidemiological study showed that 
MO and MA are distinct disorders.
3 In that study, the 
relative risk of MO and MA among first-degree relatives 
was estimated. Compared with the general population, 
first-degree relatives of probands with MO had a 1.9 
fold increased risk of MO and 1.4 fold increased risk of 
MA. Whereas first degree relatives of probands with 
MA had a 3.8 fold increased risk of MA but no 
increased risk of MO.
Population-based twin studies
In a population-based twin study, the concordance 
rates of diagnosis of MA or MO by two physicians were 
estimated. The pair-wise concordance rate was signifi-
cantly higher in monozygotic twins than in dizygotic 
twins.
4,5 The result indicates that a genetic factor is a 
major contributor to the pathogenesis of both MO and 
MA. Several epidemiological studies, in spite of 
different methods in classifying migraine and demo-
graphical factors, have shown similar results.
6.7 To 
overcome the limitation of small sample sizes, the 
GenomEUtwin consortium was founded combining twin 
registers and twin cohorts from seven European 
countries and Australia. This project will provide 
powerful information about standardized phenotypic data 
from nearly 30,000 twin pairs for migraine studies.
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Population-based segregation analysis
A population-based segregation analysis was done to 
show the mode of inheritance of migraine. According to 
the report, MA and MO have a non-mendelian 
multifactorial inheritance.
9
POSSIBLE GENETIC LOCI
Because migraine is a common disorder showing 
complex genetic traits and the influence of environ-
mental factors, it is difficult to discover genetically 
susceptible loci.
Genome-wide screens on migraine families
There have been several genome-wide screens so far 
to randomly search for genetically susceptible loci in 
common forms of migraine. A well-defined diagnosis of 
MA, MO or other types of headache is important 
because genetic susceptibility among each subtypes may 
be different. As shown in epidemiological studies, MA 
may have a stronger genetic component than MO or 
other types of headache. Identified foci included: 4q21 
in MO Icelandic, 4q24 in MA Finnish, 6p12.2-p21.1 
MA and MO in Swedish, 11q24 in MA Canadian and 
14q21.2-q22.3 in MO Italian.
10-13 However the genome- 
wide studies in migraine have not yet reached reliable 
data. It may be due to the variability of disease 
definition and study population among these studies.
Association studies with genetic polymorphism
Several association studies have used one or two 
polymorphic sites per candidate gene. Case-control 
studies compared the frequency of alleles of a 
polymorphic genetic marker between patients and 
healthy controls. In most studies, the prevalence of gene 
polymorphisms is higher in migraineurs than in controls. 
The candidate genes known to have a significant 
association with migraine included: Dopamine D2, D4 
receptors,
14,15 dopamine β hydroxylase,
16 angiotensin 
converting enzyme,
17 serotonin transporter,
18 serotonin 
receptor,
19 the endothelin type A receptor,
20 the insulin 
receptor,
21 tumor necrosis factor-α ,
22 and methylene- 
tetrahydrofolate reductase (MTHFR) gene.
23,24 An 
association study conducted in Korea suggested that both 
elevated homocysteine level and the homozygous C677T 
mutation in the MTHFR gene were associated with MA 
(adjusted odds ratio: 4.70, 95% CI 1.44~15.29, p< 
0.01).
25 Although not specific to migraine, some poly-
morphisms may increase susceptibility to migraine attack 
and induce endophenotypic vulnerability markers.
26 
However, the role of these polymorphisms remains to be 
determined and most of these results need confirmatory 
replication studies with a larger number of patients.
Candidate region linkage studies on common types 
of migraine
Some candidate region linkage studies showed that 
loci 1q31, X124-28, X22 have been linked to MA or 
MO.
27,28,29
Single nucleotide polymorphisms in CACNA1A and 
epilepsy
A single nucleotide polymorphism in exon 8 of the 
CACNA1A gene was investigated. There is one report 
that by logistic regression, two SNPs in the immediate 
vicinity of exon 8 are responsible for the association 
with epilepsy.
30
THE GENES RESPONSIBLE FOR 
FAMILIAL HEMIPLEGIC MIGRAINE
Chromosome 19p13
In 50~70% of FHM families, mutations in the 
CACNA1A gene located at chromosome 19p13 have 
been identified. More than 15 different mutations have 
been discovered so far.
31,32 CACNA1A gene encodes the 
pore-forming  α1 subunit of Cav2.1 (P/Q-type Ca
2＋) 
channels, which are expressed in the cell bodies, 
dendrites and presynaptic terminals of most of the 
central neurons, most prominent in the cerebellar Lee JY, et al. Current Issues in Migraine Genetics 
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Purkinje cells.
32 CACNA1A mutations are related to two 
other neurologic diseases such as episodic ataxia type 2 
and spinocerebellar ataxia type 6. Moreover, all FHM 
type 1 families with cerebellar signs have shown linkage 
to chromosome 19. These results suggest that progres-
sive cerebellar ataxia may be a symptom exclusively 
related to type 1, not to other type of FHM.
32 
Voltage-gated Ca
2＋channels control important neuronal 
functions including excitability, neurotransmitter release, 
activity-dependent gene expression, neuronal survival, 
differentiation and plasticity.
31 The metabolic and bio-
chemical changes of this calcium channel dysfunction 
may depress neuronal excitability of noradrenergic 
system in locus ceruleus, periaqueductal grey and raphe 
nucleus which are associated with nociceptional 
modulation of trigeminal nucleus.
31 A recent study with 
CACNA1A knock out mice showed the increase in Ca
2＋ 
influx through a single channel and decrease in maximal 
Cav2.1 current density in neurons.
33 However, the 
overall effect of the mutation has not been established.
Chromosome 1q23
The ATP1A2 is another responsible gene for FHM. 
The mutations were found to co-segregate with the FHM 
in three French families. The ATP1A2 gene on the 
chromosome 1q23 encodes the alpha subunit of the 
Na+/K+ ATPase pump and its mutations are associated 
with FHM type 2.
34,35,36 However there are FHM 
families that are not linked either to 19p13 or 1q23. At 
least a third locus may be present.
NONFAMILIAL HEMIPLEGIC 
MIGRAINE: SPORADIC CASES
Sporadic hemiplegic migraine (SHM) is a heterogenous 
disease. More than half of the SHM patients also had 
non-hemiplegic attacks of migraine with aura and one 
third had additional attacks of migraine without aura.37 
Families of SHM patients had an increased risk of 
migraine both with and without aura. The clinical 
symptoms of SHM are more similar to FHM than MA.
38
THE ASSOCIATION BETWEEN THE 
FHM AND MA / OR MO
Some of the patients with FHM also experience either 
MA or MO. It can be hypothesized that FHM is an 
extreme of MA.
32 Linkage analysis for MA with 
FHM/or SHM showed a new locus on 19q13 distinct 
from CACNA1A.
39 According to the epidemiological 
data, there is still controversy in the risk of developing 
specific migraine phenotype in specific migraine 
families. Thus, the link between mendelian FHM and 
MA/or MO remains to be consolidated.
32
HEREDITARY DISEASES 
ASSOCIATED WITH MIGRAINE
CADASIL
MA occurs in many patients with CADASIL. 
However, it is not clear whether migraine attacks are 
directly related to the genetic abnormality in CADASIL 
(Notch 3 gene mutation). MA may be a secondary 
phenomenon due to underlying vascular changes. A 
mutation in the Notch 3 gene was recently found in an 
Italian family affected by migraine with prolonged aura 
but without other neurologic deficits.
40
Mitochondrial disease
MELAS is a well-known mitochondrial disease with 
migrainous headache. The association between migraine 
and mitochondrial gene is inferred by another example 
of cyclic vomiting syndrome (CVS), which is thought to 
be mitochondrial in its origin. There is a survey of 62 
children with severe CVS showing migraine, myopathy, 
seizures and dysautonomia-like symptoms. The report 
stated that it was far more common in matrilineal versus 
non-matrilineal relatives. Therefore, it was suggested that 
mitochondrial DNA sequence variants may be risk 
factors for a severe end of the CVS.
41,42Journal of Clinical Neurology: Vol. 1, No. 1, 2005
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CONCLUSION
During the past decades, epidemiological and mole-
cular studies have brought us to new insights in under-
standing migraine. First, migraine is a complex disorder 
associated with certain genetic backgrounds interrelated 
with multiple environmental factors. Second, the genetic 
heterogeneity is confirmed by many molecular studies 
using linkage analysis with alleged genes or genome- 
wide screens, SNP analysis with polymorphisms and 
association studies. Third, although migraine has 
variable clinical phenotypes, it may share common 
pathophysiology. After discovering CACNA1A gene 
mutation, a P/Q type calcium channel dysfunction and 
its role in migraine pathogenesis at the genetic level 
suggests that migraine may be a channelopathy. 
Exploring the correlation between phenotype and 
genotype of migraine may be an important next step in 
studying migraine genetics. 
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